Miltenyi Biotec is a medical services provider focused on advancing human health through innovative cellular technology solutions. The company manufactures a range of products designed for biomedical research, catering to various fields including immunology, stem cell biology, neuroscience, and cancer research. Additionally, Miltenyi Biotec supports clinical research in areas such as hematology, graft engineering, and apheresis. By offering specialized tools for cell separation, labeling, and analysis, the company aims to enhance the capabilities of researchers and clinicians worldwide.
Sensovation AG engages designs, develops, manufactures, and distributes camera based sensors and electro optical measurement systems for biotechnology, medical technology, and diagnostics applications. It offers cameras, such as SamBa Ci that is used for the inspection of solar cells; coolSamBa HR-830 that is used for the electroluminescence inspection of modules in photovoltaic industries.
Lentigen Corporation, a biotechnology company, engages in the development and commercialization of gene delivery technologies for human disease. It provides lentiviral vector technology for a range of therapeutic, vaccine, and research applications in biotechnology and medicine. The company offers LG690, a cell therapy for treatment of graft vs hot diseases; LG768, a cancer vaccine for the treatment of leukemia; stem cell therapy to prevent and treat medical disorders; LG631, a treatment that makes chemotheraphy for brain cancer less toxic; LG889, a steam cell therapy for hemophilia; LG611, an exact strain matched influenza vaccine for pandemic flu; LG811, an exact strain matched influenza vaccine for seasonal flu; LG747, a biosimilar erytho poieitin; and LG888, a novel factor VIII protein therapy for Hemophilia A. Lentigen Corporation was founded in 2004 and is headquartered in Gaithersburg, Maryland.
Eligix
Acquisition in 2003
Eligix, Inc., a biomedical company, engages in the research and development of cellular therapies. The therapies improve human immune response to cancers, autoimmune disorders, and solid organ transplants; and reduce the risk of infection and hypersensitivity reactions in blood transfusions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.